LEETRO
430425
Geovis Insighter Technology
920116
Beijing Global Safety Technology
300523
4
Zhejiang JW Precision Machinery
300984
5
Wintao Communications
301139
CN Stock MarketDetailed Quotes
300181 Zhejiang Jolly Pharmaceutical
- 14.73
- -0.20-1.34%
Market Closed Mar 5 15:00 CST
10.33BMarket Cap19.96P/E (TTM)
14.94High14.62Low112.24KlotVolume14.88Open14.93Pre Close165.30MTurnover1.87%Turnover Ratio26.98P/E (Static)701.39MShares18.5052wk High3.97P/B8.85BFloat Cap10.2852wk Low17.92Limit Up601.08MShs Float18.50Historical High11.94Limit Down2.14%Amplitude1.02Historical Low0.45Dividend TTM14.73Avg Price63.13KlotAsk3.05%Div YieldTTM100Lot Size45.84KlotBid
Zhejiang Jolly Pharmaceutical News
Zuli Pharmaceutical: Announcement on the completion of the non-transactional transfer of shares transferred for the first time in the 2024 Employee Stock Ownership Plan
Zuli Pharmaceutical: Supervisory Board\'s Review Opinions on the List of Incentives Granted for the First Time in the 2024 Restricted Stock Incentive Plan (as of the grant date)
Zuoli Pharmaceutical: Announcement on granting restricted shares for the first time to incentive recipients of the 2024 Restricted Stock Incentive Program
Zuli Pharmaceutical: List of recipients of incentives granted for the first time in the 2024 Restricted Stock Incentive Plan (as of the grant date)
Zuoli Pharmaceutical: Legal Opinion of Shanghai Oriental Huayin Law Firm on the 2024 Restricted Stock Incentive Plan Adjustment and First Grant of Zhejiang Zuoli Pharmaceutical Co., Ltd.
Zuoli Pharmaceutical: Announcement on matters relating to the adjustment of the company\'s 2024 restricted stock incentive plan
Zuoli Pharmaceutical: Self-inspection report on the 2024 Restricted Stock Incentive Plan insider\'s stock trading situation
Zuoli Pharmaceutical: Explanation of the Supervisory Committee\'s disclosure and verification opinions on the 2024 Restricted Stock Incentive Plan incentive list
Zuoli Pharmaceutical: Self-inspection Form for Equity Incentive Plans for GEM Listed Companies
Zuli Pharmaceuticals: 2024 Restricted Stock Incentive Plan (Draft)
Zuoli Pharmaceutical: Legal Opinion of Shanghai Oriental Huayin Law Firm on Zhejiang Zuoli Pharmaceutical Co., Ltd.\'s 2024 Restricted Stock Incentive Plan
Zuoli Pharmaceutical: Announcement on changing the use of repurchased shares
Zuli Pharmaceuticals: 2024 Restricted Stock Incentive Plan (Draft) Summary
Zuli Pharmaceuticals: 2024 Restricted Stock Incentive Plan Incentive List
Zuoli Pharmaceutical: Supervisory Board\'s Inspection Opinions on Matters Related to the Company\'s 2024 Employee Stock Ownership Plan and Restricted Stock Incentive Plan
Zuoli Pharmaceutical: Announcement on the repurchase of the company\'s shares reaching 2% and the completion of the repurchase
Zuoli Pharmaceutical: Announcement on the repurchase ratio of the company\'s shares reaching 1% and the progress of the repurchase
Zhejiang Jolly Pharmaceutical: Announcement Regarding the Company's First Share Repurchase
Zhejiang Jolly Pharmaceutical: Announcement regarding the progress of repurchasing company shares.
Zhejiang Jolly Pharmaceutical: Announcement on the shareholder holdings of the top ten shareholders and the top ten unrestricted shareholders regarding share repurchase matters.